Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA? (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (UC)
Previous Study | Return to List | Next Study

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01848561
Recruitment Status : Recruiting
First Posted : May 7, 2013
Last Update Posted : September 18, 2019
Sponsor:
Information provided by (Responsible Party):
AbbVie

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 6, 2027
Estimated Study Completion Date : April 6, 2027